Showing results (1311-1320 of 13,820) with videos related to
Sort By:
Pageof 1,382
Annals of Surgical Oncology|September 30, 2024
Essential Elements in Synoptic Operative Reports for Hepato-Pancreato-Biliary Cancer Surgery: An HPB/CGSO Training Program SurveyLyonell B Kone, David Seok, Mabel M Kimble, et al.Annals of Surgical Oncology|September 29, 2024
Disappearing Signet Ring Cell Adenocarcinoma in Gastric Cancer PatientsAravind Sreeram, Emily E Stroobant, Monika Laszkowska, et al.Annals of Surgical Oncology|September 28, 2024
National Trends and In-Hospital Outcomes for Immediate Implant-Based Versus Autologous-Based Breast Reconstruction: A Propensity Score-Matched AnalysisAli Esparham, Saeed Shoar, Jennifer Whittington, et al.Annals of Surgical Oncology|September 28, 2024
Association of Neoadjuvant Immunotherapy With Postoperative Major Morbidity After Oncologic SurgeryDaniel R S Habib, Matthew Shou, Ramez H Philips, et al.Annals of Surgical Oncology|September 28, 2024
Impact of Tumoral β2-Adrenergic Receptor Expression on Chemotherapeutic Response and Prognosis in Patients with Advanced Colorectal CancerChika Komine, Makoto Sohda, Takehiko Yokobori, et al.Annals of Surgical Oncology|September 24, 2024
Oncologic and Perioperative Outcomes of Robot-Assisted Versus Conventional Laparoscopy for the Treatment of Clinically Uterine-Confined High-Grade AdenocarcinomaChristian Dagher, Yu Hui Lim, Yukio Sonoda, et al.Annals of Surgical Oncology|September 25, 2024
National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast CancerLeah S Kim, Miranda S Moore, Eric Schneider, et al.Annals of Surgical Oncology|September 23, 2024
Adult Prostate Sarcoma: Demographics, Treatment Patterns, and SurvivalCarolin Siech, Mario de Angelis, Francesco Di Bello, et al.Annals of Surgical Oncology|September 21, 2024
Plasma Ceramide C24:0/C16:0 Ratio is Associated with Improved Survival in Patients with Pancreatic Ductal AdenocarcinomaJoshua D Mitchell, Usman Panni, Nicole Fergestrom, et al.Annals of Surgical Oncology|September 17, 2024
ASO Author Reflections: The Gustave Roussy Immune Score May Be a Useful Biomarker for Conversion Surgery After Chemotherapy Plus Nivolumab as the First-Line Treatment for Gastric CancerNobuhiro Nakazawa, Akihiko Sano, Makoto Sakai, et al.Pageof 1,382